Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Urban

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|May 2, 2016
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex BAntje Blank, Christoph Markert, Nicolas Hohmann, et al.
Viruses|September 28, 2021
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-InfectionImme Roggenbach, Xiumei Chi, Florian A Lempp, et al.
Viruses|December 28, 2021
A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus InfectionFlorian A Lempp, Imme Roggenbach, Shirin Nkongolo, et al.
Journal of Virology|May 15, 2015
Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In VitroAlexander Hoh, Maximilian Heeg, Yi Ni, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gastroenterology|December 24, 2013
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytesYi Ni, Florian A Lempp, Stefan Mehrle, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|May 2, 2016
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex BAntje Blank, Christoph Markert, Nicolas Hohmann, et al.
Viruses|September 28, 2021
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-InfectionImme Roggenbach, Xiumei Chi, Florian A Lempp, et al.
Viruses|December 28, 2021
A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus InfectionFlorian A Lempp, Imme Roggenbach, Shirin Nkongolo, et al.
Journal of Virology|May 15, 2015
Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In VitroAlexander Hoh, Maximilian Heeg, Yi Ni, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gastroenterology|December 24, 2013
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytesYi Ni, Florian A Lempp, Stefan Mehrle, et al.
Pageof 14